Sign Up to like & get
recommendations!
0
Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0247556
Abstract: Background Few microRNAs were found consistently dysregulated in type 2 diabetes (T2D) that would gain confidence from Big Pharma to develop diagnostic or therapeutic biomarkers. This study aimed to corroborate evidence from eligible microRNAs-T2D association…
read more here.
Keywords:
meta analyses;
microrna biomarkers;
biomarkers type;
evidence ... See more keywords